a unique new oral contraceptive called Yasmin
Health Canada has approved a unique new oral contraceptive called Yasmin.
It contains 30 mcg of ethinyl estradiol...plus a different progestin called drospirenone.
Drospirenone is a spironolactone analogue that has anti-androgenic AND antimineralocorticoid activity.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote